1 completed, 1 recruiting, 1 suspended. 1 Early Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Suspended 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Wood smoke: new trials by email Literature Review of Wood smoke trials Research Report on Wood smoke
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Woodsmoke Exposure, Influenza Infection, and Nasal Immunity LAIV nasal vaccine is chosen as a model viral infection, Wood smoke, Placebo for LAIV nasal vaccine is chosen as a model viral infection - Smoke Exposure, Influenza | Phase 4 | Recruiting | University of North Carolina, Chapel Hill | 112 | 2025-09-26 | 2026-04-30 |
| Cardiovascular Effects of Exposure to Wood Smoke in Healthy Human Adults Filtered Air, Wood Smoke - Healthy | Not applicable | Suspended | University of North Carolina, Chapel Hill | 80 | 2021-05-25 | 2025-06-12 |
| Effects of Wood Smoke Particles on Influenza-induced Nasal Inflammation in Normal Volunteers wood smoke, clean air - Response of Viral Infection to Woodsmoke | Early Phase 1 | Completed | University of North Carolina, Chapel Hill | 39 | 2014-07-01 | 2015-06-11 |
Influenza, Human (2)
University of North Carolina, Chapel Hill (3)
United States (3)
Terry Noah, MD (2) · James Samet, PhD (1) · Meghan Rebuli, PhD (1)
R01ES013611 (1), R01ES036209 (1)